Structural Insights into the Protease-like Antigen Plasmodium falciparum SERA5 and Its Noncanonical Active-Site Serine

Journal of Molecular Biology

Volumn 392, Issue 1, 2009, Pages 154-165

  Hodder, Anthony N ^a   Malby, Robyn L ^a   Clarke, Oliver B ^a,b   Fairlie, W Douglas ^a   Colman, Peter M ^a   Crabb, Brendan S ^a   Smith, Brian J ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Plasmodium falciparum; SERA5; structure; X ray crystallography

Indexed keywords

ANTIGEN; CYSTEINE PROTEINASE; PROTEINASE; SERINE; SERINE REPEAT ANTIGEN 5; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; ENZYME STRUCTURE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; STRUCTURE ANALYSIS;

PLASMODIUM FALCIPARUM;

EID: 68949172361     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.07.007     Document Type: Article

References (61)

1. Delplace P., Bhatia A., Cagnard M., Camus D., Colombet G., Debrabant A., et al. Protein p126: a parasitophorous vacuole antigen associated with the release of Plasmodium falciparum merozoites. Biol. Cell. 64 (1988) 215-221
2. Pang X.L., Mitamura T., and Horii T. Antibodies reactive with the N-terminal domain of Plasmodium falciparum serine repeat antigen inhibit cell proliferation by agglutinating merozoites and schizonts. Infect. Immun. 67 (1999) 1821-1827
3. Blackman M.J. Malarial proteases and host cell egress: an 'emerging' cascade. Cell. Microbiol. 10 (2008) 1925-1934
4. Aoki S., Li J., Itagaki S., Okech B.A., Egwang T.G., Matsuoka H., et al. Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth. J. Biol. Chem. 277 (2002) 47533-47540
5. Bzik D.J., Li W.B., Horii T., and Inselburg J. Amino acid sequence of the serine-repeat antigen (SERA) of Plasmodium falciparum determined from cloned cDNA. Mol. Biochem. Parasitol. 30 (1988) 279-288
6. Eakin A.E., Higaki J.N., McKerrow J.H., and Craik C.S. Cysteine or serine proteinase?. Nature 342 (1989) 132
7. Hodder A.N., Drew D.R., Epa V.C., Delorenzi M., Bourgon R., Miller S.K., et al. Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5. J. Biol. Chem. 278 (2003) 48169-48177
8. Miller S.K., Good R.T., Drew D.R., Delorenzi M., Sanders P.R., Hodder A.N., et al. A subset of Plasmodium falciparum SERA genes are expressed and appear to play an important role in the erythrocytic cycle. J. Biol. Chem. 277 (2002) 47524-47532
9. Okech B., Mujuzi G., Ogwal A., Shirai H., Horii T., and Egwang T.G. High titers of IgG antibodies against Plasmodium falciparum serine repeat antigen 5 (SERA5) are associated with protection against severe malaria in Ugandan children. Am. J. Trop. Med. Hyg. 74 (2006) 191-197
10. Fairlie W.D., Spurck T.P., McCoubrie J.E., Gilson P.R., Miller S.K., McFadden G.I., et al. Inhibition of malaria parasite development by a cyclic peptide that targets the vital parasite protein SERA5. Infect. Immun. 76 (2008) 4332-4344
11. Knapp B., Hundt E., Nau U., and Kupper H.A. Molecular cloning, genomic structure and localization in a blood stage antigen of Plasmodium falciparum characterized by a serine stretch. Mol. Biochem. Parasitol. 32 (1989) 73-83
12. Knapp B., Nau U., Hundt E., and Kupper H.A. A new blood stage antigen of Plasmodium falciparum highly homologous to the serine-stretch protein SERP. Mol. Biochem. Parasitol. 44 (1991) 1-13
13. Debrabant A., Maes P., Delplace P., Dubremetz J.F., Tartar A., and Camus D. Intramolecular mapping of Plasmodium falciparum P126 proteolytic fragments by N-terminal amino acid sequencing. Mol. Biochem. Parasitol. 53 (1992) 89-95
14. Li J., Matsuoka H., Mitamura T., and Horii T. Characterization of proteases involved in the processing of Plasmodium falciparum serine repeat antigen (SERA). Mol. Biochem. Parasitol. 120 (2002) 177-186
15. Li J., Mitamura T., Fox B., Bzik D., and Horii T. Differential localization of processed fragments of Plasmodium falciparum serine repeat antigen and further processing of its N-terminal 47 kDa fragment. Parasitol. Int. 51 (2002) 343-352
16. Arisue N., Hirai M., Arai M., Matsuoka H., and Horii T. Phylogeny and evolution of the SERA multigene family in the genus Plasmodium. J. Mol. Evol. 65 (2007) 82-91
17. Bourgon R., Delorenzi M., Sargeant T., Hodder A.N., Crabb B.S., and Speed T.P. The serine repeat antigen (SERA) gene family phylogeny in Plasmodium: the impact of GC content, and reconciliation of gene and species trees. Mol. Biol. Evol. 21 (2004) 2161-2171
18. McCoubrie J.E., Miller S.K., Sargeant T., Good R.T., Hodder A.N., Speed T.P., et al. Evidence for a common role for the serine-type Plasmodium falciparum SERA proteases: Implications for vaccine and drug design. Infect. Immun. 75 (2007) 5565-5574
19. Yeoh S., O'Donnell R.A., Koussis K., Dluzewski A.R., Ansell K.H., Osborne S.A., et al. Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes. Cell 131 (2007) 1072-1083
20. Koussis K., Withers-Martinez C., Yeoh S., Child M., Hackett F., Knuepfer E., et al. A multifunctional serine protease primes the malaria parasite for red blood cell invasion. EMBO J. 28 (2009) 725-735
21. Arastu-Kupur S., Ponder E.L., Fonovic U.P., Yeoh S., Yuan F., Fonovic M., et al. Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum. Nat. Chem. Biol. 4 (2008) 203-213
22. Pils B., and Schultz J. Inactive enzyme-homologues find new function in regulatory processes. J. Mol. Biol. 340 (2004) 399-404
23. Sato D., Li J., Mitamura T., and Horii T. Plasmodium falciparum serine-repeat antigen (SERA) forms a homodimer through disulfide bond. Parasitol. Int. 54 (2005) 261-265
24. Grima J., Zhu L.J., Zong S.D., Catterall J.F., Bardin C.W., and Cheng C.Y. Rat testin is a newly identified component of the junctional complexes in various tissues whose mRNA is predominantly expressed in the testis and ovary. Biol. Reprod. 52 (1995) 340-355
25. Shimizu K., Cha J., Stucky G.D., and Morse D.E. Silicatein α: cathepsin L-like protein in sponge biosilica. Proc. Natl Acad Sci. USA 95 (1998) 6234-6238
26. Brutchey R.L., and Morse D.E. Silicatein and the translation of its molecular mechanism of biosilicification into low temperature nanomaterial synthesis. Chem. Rev. 108 (2008) 4915-4934
27. Fairhead M., Johnson K.A., Kowatz T., McMahon S.A., Carter L.G., Oke M., et al. Crystal structure and silica condensing activities of silicatein α-cathepsin L chimeras. Chem. Commun. (2008) 1765-1767
28. Kalfa T.A., Thull J.D., Butkowski R.J., and Charonis A.S. Tubulointerstitial nephritis antigen interacts with laminin and type IV collagen and promotes cell adhesion. J. Biol. Chem. 269 (1994) 1654-1659
29. Holm L., and Park J. DaliLite workbench for protein structure comparison. Bioinformatics 16 (2000) 566-567
30. Caffrey C.R., Hansell E., Lucas K.D., Brinen L.S., Hernandez A.A., Cheng J., et al. Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense. Mol. Biochem. Parasitol. 118 (2001) 61-73
31. Gillmor S.A., Craik C.S., and Fletterick R.J. Structural determinants of specificity in the cysteine protease cruzain. Protein Sci. 6 (1997) 1603-1611
32. Biswas S., Chakrabarti C., Kundu S., Jagannadham M.V., and Dattagupta J.K. Proposed amino acid sequence and the 1.63 Å X-ray crystal structure of a plant cysteine protease, ervatamin B: some insights into the structural basis of its stability and substrate specificity. Proteins 51 (2003) 489-497
33. Chowdhury S., Sivaraman J., Wang J., Devanathan G., Lachance P., Qi H., et al. Design of non-covalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides. J. Med. Chem. 45 (2002) 5321-5329
34. Turk D., Guncar G., Podobnik M., and Turk B. Revised definition of substrate binding sites of papain-like cysteine proteases. Biol. Chem. 379 (1998) 137-147
35. Turk D., and Guncar G. Lysosomal cysteine proteases (cathepsins): promising drug targets. Acta Crystallogr., Sect. D: Biol. Crystallogr. D59 (2003) 203-213
36. Puzer L., Cotrin S.S., Alves M.F.M., Egborge T., Araújo M.S., Juliano M.A., et al. Comparative substrate specificity analysis of recombinant human cathepsin V and cathepsin L. Arch. Biochem. Biophys. 430 (2004) 274-283
37. Choe Y., Leonetti F., Greenbaum D.C., Lecaille F., Bogyo M., Brömme D., et al. Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities. J. Biol. Chem. 281 (2006) 12824-12832
38. Groves M.R., Coulombe R., Jenkins J., and Cygler M. Structural basis for specificity of papain-like cysteine protease proregions toward their cognate enzymes. Proteins 32 (1998) 504-514
39. Musil D., Zucic D., Turk D., Engh R.A., Mayr I., Huber R., et al. The refined 2.15 Å X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J. 10 (1991) 2321-2330
40. 2. Biochem. J. 401 (2007) 645-650
41. Guncar G., Podobnik M., Pungercak J., Strukelj B., Turk V., and Turk D. Crystal structure of procine cathepsin H determined at 2.1 Å resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function. Structure 6 (1998) 51-61
42. Meno K., Thorsted P.B., Ipsen H., Kristensen O., Larsen J.N., Spangfort M.D., et al. The crystal structure of recombinant proDer p 1, a major house dust mite proteolytic allergen. J. Immunol. 175 (2005) 3835-3845
43. de Halleux S., Stura E., VanderElst L., Carlier V., Jacquemin M., and Saint-Remy J.M. Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major allergen. J. Allergy Clin. Immunol. 117 (2006) 571-576
44. Hewitt C.R.A., Brown A.P., Hart B.J., and Pritchard D.I. A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases. J. Exp. Med. 182 (1995) 1537-1544
45. Schulz O., Sewell H.F., and Shakib F. Proteolytic cleavage of CD25, the α subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. J. Exp. Med. 187 (1998) 271-275
46. O'Hara B.P., Hemmings A.M., Buttle D.J., and Pearl L.H. Crystal structure of glycyl endopeptidase from Carica papaya: a cysteine endopeptidase of unusual substrate specificity. Biochemistry 34 (1995) 13190-13195
47. Coulombe R., Grochulski P., Sivaraman J., Menard R., Mort J.S., and Cygler M. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J. 15 (1996) 5492-5503
48. Podobnik M., Kuhelj R., Turk V., and Turk D. Crystal structure of the wild-type human procathepsin B at 2.5 Å resolution reveals the native active site of a papain-like cysteine protease zymogen. J. Mol. Biol. 271 (1997) 774-788
49. Aly A.S.I., and Matuschewshi K. A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts. J. Exp. Med. 202 (2005) 225-230
50. Studier F.W. Protein production by auto-induction in high density shaking cultures. Protein Expression Purif. 41 (2005) 207-234
51. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Macromol. Crystallogr., Part A 276 (1997) 307-326
52. Pape T., and Schneider T.R. HKL2MAP: a graphical user interface for macromolecular phasing with SHELX programs. J. Appl. Crystallogr. 37 (2004) 843-844
53. Terwilliger T.C., and Berendzen J. Automated MAD and MIR structure solution. Acta Crystallogr., Sect. D: Biol. Crystallogr. 55 (1999) 849-861
54. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 (2004) 2126-2132
55. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr., Sect. D: Biol. Crystallogr. 53 (1997) 240-255
56. McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., and Read R.J. Phaser crystallographic software. J. Appl. Crystallogr. 40 (2007) 658-674
57. Alexov E.G., and Gunner M.R. Incorporating protein conformational flexibility into the calculation of pH-dependent protein properties. Biophys. J. 72 (1997) 2075-2093
58. Georgescu R.E., Alexov E.G., and Gunner M.R. Combining conformational flexibility and continuum electrostatics for calculating pK(a)s in proteins. Biophys. J. 83 (2002) 1731-1748
59. Sitkoff D., Sharp K.A., and Honig B. Accurate calculation of hydration free-energies using macroscopic solvent models. J. Phys. Chem. 98 (1994) 1978-1988
60. Nicholls A., and Honig B. A rapid finite difference algorithm utilizing successive over-relaxation to solve the Poisson-Boltzmann equation. J. Comp. Chem. 12 (1991) 435-445
61. Bashford D. An object-oriented programming suite for electrostatic effects in biological molecules. In Scientific Computing in Object-Oriented Parallel Environments. 1343 of Lecture Notes in Computer Science (1997), Springer, Berlin 233-240